Down Syndrome Screening in Singapore - The Effectiveness of a Second Trimester Serum Screening Policy Modelled on 29,360 Pregnancies in KK Women's and Children's Hospital

Singapore Medical Journal

Volumn 39, Issue 2, 1998, Pages 69-75

  Lai, F M ^a   Yeo, G S H ^a  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

Author keywords

Down syndrome; Modelling; Serum screening; Singapore

Indexed keywords

AMNIOCENTESIS; ARTICLE; BLOOD; COMPARATIVE STUDY; CONGENITAL MALFORMATION; DOWN SYNDROME; FEMALE; HUMAN; MALE; MANAGEMENT; MASS SCREENING; MATERNAL AGE; METHODOLOGY; NEWBORN; ORGANIZATION AND MANAGEMENT; PREDICTION AND FORECASTING; PREGNANCY; REGISTER; ROC CURVE; SECOND TRIMESTER PREGNANCY; SINGAPORE;

ABNORMALITIES; AMNIOCENTESIS; DOWN SYNDROME; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MASS SCREENING; MATERNAL AGE; POLICY MAKING; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; REGISTRIES; ROC CURVE; SINGAPORE;

EID: 0031990146     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Penrose LS, Smith GF, Down's Anomaly. Boston: Little Brown & Co, 1966.
2. Yeo GSH, Ali AA. The effect of prenatal diagnosis on the incidence of Down Syndrome livebirths in the Singapore General Hospital. Singapore Med J 1992; 33(1):38-41.
3. Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 1987; 94:387-402.
4. Ferguson-Smith MA, Yates JRW. Maternal age specific rates for chromosomal aberrations and factors influencing them: report of a collaborative European study on 52,965 amniocentesis. Prenat Diagn. 1984: 4:5-44.
5. Cuckle HS, Wald NJ. Screening for Down's syndrome. In: Richard Lilford, editor. Prenatal Diagnosis and Prognosis. London: Butterworths, 1990: 67-89.
6. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T et al. Maternal serum screening for Down's syndrome in early pregnancy. Br Med J 1988; 297:883-7.
7. Wald NJ, Cuckle HS, Densem JW, Kennard A, Smith D. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Br J Obstet Gynaecol 1992, 99:144-9.
8. Bishop J, Dunstan FDJ, Nix BJ, Reynolds TM. The effects of gestation dating on the calculation of patient specific risks in Down's syndrome screening. Ann Clin Biochem 1995; 32:464-77.
9. Gardosi J, Mongelli M. Risk assessment adjusted for gestational age in maternal serum screening for Down's syndrome. Br Med J 1993, 306:1509-11.
10. Parvin CA, Gray DL, Kessler G. Influence of assay method differences on multiple of the median distributions: maternal serum alpha-fetoprotein as an example. Clin Chem 1991; 37:637-42.
11. Hecht CA, Hook EB. The imprecision in rates of Down syndrome by 1-year maternal age intervals: a critical analysis of rates used in biochemical screening. Prenat Diagn 1994; 14:729-38.
12. Wald NJ, Densem JW Smith D, Klee GG. Four-marker serum screening for Down's syndrome. Prenat Diagn 1994; 14:707-16
13. Cuckle H . Improved parameters for risk estimation in Down's syndrome screening. Prenat Diagn 1995; 15:1057-65.
14. Cuckle H, Nanchahal K, Wald N. Birth prevalence of Down's syndrome in England and Wales. Prenat Diagn 1991; 11:29-34
15. Marteau TM, Kidd J, Cook R, Michie S, Johnston M, Slack J, et al. Perceived risk not actual risk predicts uptake of amniocentesis. Br J Obstct Gynaecol 1991; 98:282-6.
16. Julian-Reyniew C, Macquart-Moulin G, Moatti JP, Aurran Y, Chabal F, Ayme S. Reasons for women's non-uptake of amniocentesis. Prenat Diagn 1994; 14:859-64.
17. Smith DK, Shaw RW, Marteau TM. Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice. Br Med J 1994; 309:776.
18. McCraken DD. The Monte Carlo Method, Scientific American, May 1955: 90-6.
19. Royal College of Obstetricians and Gynaecologists. Report of the RCOG Working Party on biochemical markers And the detection of Down's syndrome. London: RCOG press, 1993.
20. Cuckle H. Maternal serum screening policy for Down's syndrome. Lancet 1992; 340:799.
21. Cuckle H, Lilford R Antenatal screening for Down's syndrome. Br Med J 1992; 305:1017.
22. C Toh. Impact of A Free Market System on Medicine in Singapore. Singapore Med J 1997; 38:7-10.
23. Wald N, Wald K, Smith D. The extent of Down's syndrome screening in Britain in 1991 Lancet 1992; 340:494.
24. Cuckle HS, Wald NJ, Nanchahal K, Densem J Repeat maternal serum alpha-fetoprotein testing in antenatal screening programmes for Downs syndrome. Br J Obstet Gynaecol 1989; 96:52-6.
25. Dick PT Canadian Task Force on the Periodic Health Examination: The periodic health examination, 1996 update: Prenatal screening for and diagnosis of Down Syndrome. Can Med Assoc J 1996; 154:465-79.